Aspira Pathlab & Diagnostics Ltd shares jump 1.95% as SEBI gets disclosure under Regulation 29(2) for Jay Arvind Bhanushali
Why did Aspira Pathlab & Diagnostics Ltd shares jump today?
Aspira Pathlab & Diagnostics Ltd shares experienced a notable jump today, rising by 1.95%. The stock, which was trading at ₹91.5, saw this upward movement as of Friday at 05:13 PM. This positive response in the market is directly linked to a significant regulatory disclosure made by the company.
The Exchange received an important disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. This specific regulation pertains to substantial acquisitions of shares and takeover situations. The disclosure was filed in relation to Jay Arvind Bhanushali, indicating a substantial change in his shareholding in the company.
Such filings are closely watched by the market as they can signal a major investor's confidence in the company's future prospects. The announcement of a substantial acquisition or change in stake often suggests strategic interest and can lead to increased investor optimism, which likely contributed to the share price rise.
What does Aspira Pathlab & Diagnostics Ltd do?
No information about Aspira Pathlab & Diagnostics Ltd is contained within the provided text. Therefore, a description of its business cannot be generated based on the available facts.
Aspira Pathlab & Diagnostics Ltd Financials
In CroresAspira Pathlab & Diagnostics Ltd showed a positive revenue trend, growing from ₹5.12 Crores in December 2025 to ₹6.52 Crores in March 2026, representing an increase of approximately 27.3% over the quarter. On the profit front, the company reported a net loss of ₹1.56 Crores in December 2025, which narrowed significantly to a loss of ₹0.69 Crores in March 2026, indicating a substantial improvement in profitability as losses were reduced by more than half. While the company remained in the red during this period, the simultaneous rise in revenue and reduction in losses suggests an improving operational trajectory.
Aspira Pathlab & Diagnostics Ltd Shareholding Pattern
Promoter holding stands at 46.58% of the total share capital. Foreign Institutional Investors (FIIs) hold 0.0% stake in the company, while Domestic Institutional Investors (DIIs) hold 0.0%. Public shareholders hold the remaining 53.41% stake in Aspira Pathlab & Diagnostics Ltd.
Aspira Pathlab & Diagnostics Ltd FAQs
Q: Why did Aspira shares jump 1.95% today?
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Aspira Pathlab & Diagnostics Ltd?
As per the latest data, promoters hold 46.58% stake in Aspira Pathlab & Diagnostics Ltd, while FII holding stands at 0.0%. Domestic institutional investors hold 0.0%, and public shareholders account for 53.41% of the equity.
Q: What is the current stock price of Aspira Pathlab & Diagnostics Ltd?
Aspira Pathlab & Diagnostics Ltd shares are currently trading at ₹91.5, recording a gain of 1.95% from the previous close.
Q: What is the market capitalization of Aspira Pathlab & Diagnostics Ltd?
The company currently has a market capitalization of ₹94.18 crore, reflecting its valuation in the Indian equity market.